These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2483306

  • 1. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O, Bissonnette E, Madarnas P, Nigam VN.
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
    Benrezzak O, Madarnas P, Pageau R, Nigam VN, Elhilali MM.
    Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic antiangiogenic tumor treatment.
    Madarnas P, Benrezzak O, Nigam VN.
    Anticancer Res; 1989; 9(4):897-901. PubMed ID: 2479330
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. II. Pathological studies.
    Madarnas P, Benrezzak O, Pageau R, Nigam VN, Elhilali M.
    Anticancer Res; 1989; 9(6):1889-95. PubMed ID: 2627135
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic electromagnetic field effects on angiogenesis and tumor growth.
    Williams CD, Markov MS, Hardman WE, Cameron IL.
    Anticancer Res; 2001; 21(6A):3887-91. PubMed ID: 11911264
    [Abstract] [Full Text] [Related]

  • 6. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
    Benrezzak O, Madarnas P, Pageau R, Nigam VN.
    In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
    [Abstract] [Full Text] [Related]

  • 7. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S, Lockhart AC, Saito WY, Knapp AM, Laderoute KR, Dewhirst MW.
    Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.
    Lee JC, Kim DC, Gee MS, Saunders HM, Sehgal CM, Feldman MD, Ross SR, Lee WM.
    Cancer Res; 2002 Feb 01; 62(3):747-55. PubMed ID: 11830529
    [Abstract] [Full Text] [Related]

  • 9. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH, Nigam VN, Brailovsky CA, Backman BD, Elhilali MM.
    Cancer Res; 1984 Feb 01; 44(2):536-42. PubMed ID: 6537897
    [Abstract] [Full Text] [Related]

  • 10. Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
    Nigam VN, Brière N, Bonaventure J, Pageau R, Bissonnette E, Brailovsky C, Madarnas P.
    Anticancer Res; 1986 Feb 01; 6(2):245-50. PubMed ID: 3085575
    [Abstract] [Full Text] [Related]

  • 11. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
    Ching LM, Joseph WR, Baguley BC.
    Anticancer Res; 1993 Feb 01; 13(6A):2069-75. PubMed ID: 8297115
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
    Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW.
    Cancer Res; 2002 Mar 15; 62(6):1702-6. PubMed ID: 11912143
    [Abstract] [Full Text] [Related]

  • 13. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
    Vaage J, Costanza ME.
    Cancer Res; 1979 Nov 15; 39(11):4466-71. PubMed ID: 498077
    [Abstract] [Full Text] [Related]

  • 14. Hyperbaric pressure effects measured by growth of a transplantable tumor in the C3H/HeN mouse.
    Herndon BL, Lally JJ.
    J Natl Cancer Inst; 1984 Sep 15; 73(3):679-87. PubMed ID: 6590914
    [Abstract] [Full Text] [Related]

  • 15. Effect of metronidazole on the C3H/HeJ mouse and growth of the C3HBA mammary adenocarcinoma.
    Inch WR, McCredie JA, Haynes MJ, Sutherland RM.
    Growth; 1977 Mar 15; 41(1):15-23. PubMed ID: 858527
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of anti-vascular therapy with texture analysis.
    Chen G, Jespersen S, Pedersen M, Pang Q, Horsman MR, Stødkilde Jørgensen H.
    Anticancer Res; 2005 Mar 15; 25(5):3399-405. PubMed ID: 16101155
    [Abstract] [Full Text] [Related]

  • 17. Induction of antitumor immunity employing live tumor cells and maltose tetrapalmitate.
    Bonaventure J, Nigam VN, Brailovsky CA.
    J Biol Response Mod; 1985 Jun 15; 4(3):258-63. PubMed ID: 4020385
    [Abstract] [Full Text] [Related]

  • 18. The effects of epirubicin hydrochloride (EPI) plus pretreatment of medroxyprogesterone acetate (MPA) on FM3A breast cancer cells transplanted in female C3H/He mice.
    Yuyama Y, Yagihashi A, Hirata K, Suzuki Y, Ohmura T, Okazaki M, Watanabe N.
    In Vivo; 2003 Jun 15; 17(3):251-4. PubMed ID: 12929575
    [Abstract] [Full Text] [Related]

  • 19. Effect of 3,5,3'-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN mice.
    Sellitti DF, Tseng YC, Latham KR.
    Cancer Res; 1981 Dec 15; 41(12 Pt 1):5015-9. PubMed ID: 7307003
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM, Joseph WR, Baguley BC.
    Anticancer Res; 1993 Dec 15; 13(4):1139-41. PubMed ID: 8352536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.